 |
| MJ Stocks on Fire with Nevada Permits Issued TRTC Leads the Way |
|
 Hot Stock to Watch
|
Company: Terra Tech Corp (OTCQB: TRTC)
|
End of Day:
Price: 0.495
Change (%): + 0.085 (20.73)
Volume: 8,351,182 |
 |
Terra Tech Receives Provisional Licenses From The State of Nevada to Operate Multiple Medical Marijuana Establishments
MediFarm subsidiaries receive eight provisional licenses throughout Nevada
Las Vegas, Nov. 4, 2014 (GLOBE NEWSWIRE) - Terra Tech Corp (TRTC) is pleased to announce that their subsidiaries, MediFarm, MediFarm I, and MediFarm II, have all received provisional licenses from the State of Nevada in each local jurisdiction where they applied for a Medical Marijuana Establishment license. Collectively, these subsidiaries were issued a total of 4 Dispensary licenses, 2 Cultivation licenses and 2 Production licenses spanning both Northern and Southern Nevada. The MediFarm subsidiaries must also obtain applicable land use permits and businesses licenses in each local jurisdiction before they can commence operations.
To date, in Southern Nevada, MediFarm, has received its land use permits in unincorporated Clark County for the Cultivation and Production facilities. The Dispensary land use permits in unincorporated Clark County are pending. MediFarm has also received its land use permit and a compliance permit in the City of Las Vegas for its Dispensary facility. MediFarm will have to apply for and obtain business licenses in both these local jurisdictions before commencing operations.
Continue Reading
|
 Yesterday's Top Performer
|
Company: United Cannabis Corp. (OTCQB: CNAB)
|
End of Day:
Price: 1.00
Change (%): + 0.15 (17.65)
Volume: 85,020 |
 |
About United Cannabis Corp.
United Cannabis Corporation is a bio cannabinoid technologies company built on scientific research, product development, and implementation of its unique proprietary cannabinoid therapy program. United Cannabis Corporation has a solid foundation in the cannabis industry, but more importantly we have benefited from the thousands of faces, stories, and lives we have come into contact with through our programs and experiences over the years. With our consulting services, management and oversight we are capable of assisting any Cannabis oriented company on any scale. United Cannabis Corporation is now partnering domestically and internationally with local businessmen, entrepreneurs, and scientists for the purpose of promoting Best Practices in Planning, Procedures, Governance and Patient Care. With access to a prolific catalog of award winning genetics (including over 15 unique CBD dominant strains) and coupled with our leadership & experience we are positioned to take any Cannabis Business through all of the steps for immediate success.
Company Information Sheet
|
Company: Medical Marijuana Inc. (Pink Sheets: MJNA)
|
End of Day:
Price: 0.197
Change (%): + 0.025 (14.53)
Volume: 13,198,017 |
 |
About Medical Marijuana Inc.
Our mission is to be the premier cannabis and hemp industry innovators, leveraging our team of professionals to source, evaluate and purchase value-added companies and products, while allowing them to keep their integrity and entrepreneurial spirit. We strive to create awareness within our industry, develop environmentally-friendly, economically sustainable businesses, while increasing shareholder value.
Company Information Sheet |
Other Small Cap News
|
Company: Regen BioPharma, Inc. (OTCBB: RGBP)
|
FDA Issues IND Number for Regen BioPharma's dCellVax Therapeutic Application, a Proposed Treatment for Breast Cancer
Once All of the FDA Comments Are Addressed, the Company Aims to Initiate Gene Silencing Immunotherapy for Metastatic Breast Cancer Patients
SAN DIEGO, CA--(Marketwired - Nov 4, 2014) - Regen BioPharma, Inc. (OTCBB: RGBP) announced today issuance of IND (Investigational New Drug Application) number 16200 from the FDA for a proposed Phase I/II clinical trial assessing safety with signals of efficacy of the dCellVax gene silenced dendritic cell immunotherapy for treating breast cancer.
The proposed trial will recruit 10 patients with metastatic breast cancer and will involve 4 monthly injections of the dCellVax gene-silenced dendritic cell therapy. The trial will last one year, with tumor assessment before therapy and at 6 and 12 months.
Continue Reading
|
Company: Cannabis Therapy Corp. (OTCQB: CTCO)
|
Canna-Pet™ Launches All New Canna-Biscuits for Dogs
All Natural Cannabidiol (CBD) Dog Treats Now Available Online!
LOS ANGELES, CA--(Marketwired - Nov 4, 2014) - Canna-Pet™ the leading American innovator of over-the-counter cannabinoid products for animals, today announced the online launch of its updated and reformulated All Natural Canna-Biscuits for Dogs.
A company representative comments, "Effective immediately, we have started shipping our exciting product to our many new and loyal customers. Canna-Biscuits for Dogs are an ideal means to introduce consumers to the health benefits that hemp-based cannabinoids offer. Our biscuits are easily administered, safe and delicious. Canna-Biscuits are particularly popular for anxious pets, as evidenced by many consumers who have reported calmer behavior during thunderstorms, travel, or during extended absences."
Continue Reading |
Market News
|
By James Detar: Investor's Business Daily
|
Apple, Alibaba Lead 5 Stocks Bolting To New Highs
With the market in a confirmed uptrend, most stocks are heading higher. But which are the real leaders? Look for companies such as Apple (NASDAQ: AAPL) that boast superior fundamentals whose stocks are outperforming the general market.
Today's Screen Of The Day is Bolting RS Lines, which includes leading stocks that are rising relative to the S&P 500. A rising RS line means that the stock is outperforming the benchmark index.
Here are five highly rated stocks with bolting Relative Strength lines, several of which may be poised for big holiday shopping gains.
Continue Reading
|
By Lawrence Lewitinn: Talking Numbers
|
Why Dow 20K may take longer than you think
The Dow Jones Industrial Average touched record highs on Monday and that has investors asking a simple - but big - question: How long before we see Dow 20k?
After a scary first half to October, the Dow rebounded and traded at 17,410.65 on Monday, its highest level ever.
So can the Dow hit 20,000, just 15.2 percent from Monday’s close, soon? After all, the Dow gained 26.5 percent in 2013.
Continue Reading
|
  |
IMPORTANT DISCLAIMER - PLEASE READ THOROUGHLY
SmallCapVoice (SCV) is an electronic publication. Information sources for our profiles include, but are not limited to, online research, member suggestions, magazines, newspapers, analyst suggestions, information provided by the profiled company, press releases and similar sources. This communication is not an offer to sell or a recommendation that you buy or sell any security. SCV holds no securities licenses and is not qualified to provide investment advice. We are compensated for these advertisements by the profiled companies. You should not use this newsletter as the sole basis for any investment decision. While all investments involve risk, microcap stocks are among the most risky. Many microcap companies have no proven track record. You should only invest in microcap companies if you can afford to lose your entire investment. You should consult a qualified, licensed financial advisor or stock broker before making any decisions to invest in the securities of any company that is described in these profiles. These profiles are paid advertisements. Although we have a reasonable belief that the information in each profile is accurate, we cannot guarantee that the information is accurate. It is important for you to verify all information by your own independent research. You are receiving this message because you have agreed to receive emails from SmallCapVoice.com. You may opt out of our distribution list at any time by clicking on the "unsubscribe" link below. Link to full disclosure about compensation paid to SmallCapVoice.com, Inc. by companies featured on our website or in our e-mail communications. |
About Penny Stocks |
|
|
